Back to Research Home
LHLaboratory Corporation of America Holdings
Health Care · Health Care Services · Large
$328.95−0.30%
As of 23 Oct 2026Mkt cap $26.9B
Stage 13
WAIT
Fundamentals
47.2/75
Technical
6.3/15
Independent
53.5/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +6.5%
- 3M
- +9.2%
- 6M
- +24.7%
- 1Y
- +16.3%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 27.2xHist median 28.2x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 23.9x
- FCF yield
- 4.2%
Quality
- ROIC
- —
- Operating margin
- 8.4%
- FCF margin
- 8.6%
- Current ratio
- 1.4x
Growth
- Revenue growth
- +7.2%Latest FY YoY
- Revenue CAGR
- +1.5%
- EPS CAGR
- −19.1%
- FCF CAGR
- −18.2%
Capital
- Share-count trend
- −2.2%3Y annualised
- Net debt
- $5.4B3.3x OCF
Annual trend
- CAGR 2021–2025
- +1.5%
- Latest · 2025
- $14B
- YoY
- +7.2%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-28
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded